Skip to main content

Meningitis C Vaccine

Volume 403: debated on Monday 7 April 2003

The text on this page has been created from Hansard archive content, it may contain typographical errors.

To ask the Secretary of State for Health what research is being conducted into meningitis; and what support is available from the Department of Health to encourage it. [105901]

[holding answer 1 April 2003]: Over the last five years, a total of approximately £4 million has been provided to the Centre for Applied Microbiology and Research (CAMR) for meningococcal research. A total of approximately £2 million has been provided to the Public Health Laboratory Service (PHLS) over the last three years for meningococcal research. In 2001, the Chief Medical Officer commissioned an audit, of £120,000 over two years, of the hospital care of adults with meningococcal disease.The Department of Health has recently provided £6.1 million over three years to the Vaccine Evaluation Consortium for further vaccine research, some of which relates to meningococcal research. Research into vaccine against Group B meningococcal disease continues as part of the work undertaken by PHLS and CAMR, now the Health Protection Agency.